Search Results

There are 2973114 results for: content related to: Prolonged (6 months) treatment of chronic hepatitis B virus infection with recombinant leukocyte A interferon

  1. THE EVOLVING ROLE OF ALPHA INTERFERON IN THE TREATMENT OF MALIGNANCIES

    Australian and New Zealand Journal of Medicine

    Volume 16, Issue 3, June 1986, Pages: 425–437, P. HERSEY

    Article first published online : 25 MAR 2008, DOI: 10.1111/j.1445-5994.1986.tb01212.x

  2. Epitopes recognized by neutralizing therapy-induced human anti-interferon-α antibodies are localized within the N-terminal functional domain of recombinant interferon-α2

    European Journal of Immunology

    Volume 26, Issue 9, September 1996, Pages: 2155–2159, Klaus-Ulrich Nolte, Gero Günther and Peter von Wussow

    Article first published online : 17 NOV 2005, DOI: 10.1002/eji.1830260929

  3. Recombinant interferon α (rIFN-α) does not potentiate the effect of iodine excess on the development of thyroid abnormalities in patients with HCV chronic active hepatitis

    Clinical Endocrinology

    Volume 50, Issue 1, January 1999, Pages: 95–100, Roberta Minelli, Lewis E. Braverman, Maria Antonietta Valli, Claudia Schianchi, Mario Pedrazzoni, Franco Fiaccadori, Mario Salvi, Maria Grazia Magotti and Elio Roti

    Article first published online : 24 DEC 2001, DOI: 10.1046/j.1365-2265.1999.00616.x

  4. You have full text access to this OnlineOpen article
    A phase I-II trial of the combination of recombinant leukocyte a interferon and recombinant human interferon-γ in patients with metastatic malignant melanoma

    Cancer

    Volume 62, Issue 12, 15 December 1988, Pages: 2472–2474, Edward T. Creagan, Charles L. Loprinzi, David L. Ahmann and Daniel J. Schaid

    Article first published online : 29 JUN 2006, DOI: 10.1002/1097-0142(19881215)62:12<2472::AID-CNCR2820621203>3.0.CO;2-G

  5. You have full text access to this OnlineOpen article
    Phase II study of recombinant leukocyte a interferon (rIFN-αA) in disseminated malignant melanoma

    Cancer

    Volume 54, Issue 12, 15 December 1984, Pages: 2844–2849, Edward T. Creagan, David L. Ahmann, S. J. Green, Harry J. Long, Joseph Rubin, Allan J. Schutt and Zofia E. Dziewanowski

    Article first published online : 29 JUN 2006, DOI: 10.1002/1097-0142(19841215)54:12<2844::AID-CNCR2820541205>3.0.CO;2-Q

  6. You have free access to this content
    Induction and increase of HLA-DR antigen expression by immune interferon on ML-3 cell line enhances the anti-HLA-DR immunotoxin activity

    Clinical & Experimental Immunology

    Volume 82, Issue 2, November 1990, Pages: 214–220, M. CHIRON, J. P. JAFFREZOU, P. CARAYON, C. BORDIER, F. ROUBINET, C. XAVIER, M. BRANDELY and G. LAURENT

    Article first published online : 28 JUN 2008, DOI: 10.1111/j.1365-2249.1990.tb05429.x

  7. Treatment of anti-recombinant interferon-alpha 2 antibody positive CML patients with natural interferon-alpha

    British Journal of Haematology

    Volume 78, Issue 2, June 1991, Pages: 210–216, P. v. Wussow, D. Jakschies, M. Freund, R. Hehlmann, F. Brockhaus, H. Hochkeppel, M. Horisberger and H. Deicher

    Article first published online : 12 MAR 2008, DOI: 10.1111/j.1365-2141.1991.tb04418.x

  8. You have open access to this content
    Changes in Lymphocyte Subsets Following Multiple Administration of Recombinant Interleukin-2 plus Recombinant Interferon-beta or -gamma in Tumor-bearing Mice

    Cancer Science

    Volume 80, Issue 6, June 1989, Pages: 554–561, Masaaki Iigo, Ken-ichi Nishikata, Yoko Nakajima and Masami Moriyama

    Article first published online : 25 AUG 2005, DOI: 10.1111/j.1349-7006.1989.tb01675.x

  9. Long-term therapeutic efficacy and toxicity of recombinant interferon-alpha 2a in polycythaemia vera

    European Journal of Haematology

    Volume 60, Issue 5, May 1998, Pages: 273–277, P. Foa, P. Massaro, S. Caldiera, M L. LaTargia, A. Iurlo, C. Clerici, M. Fornier, F. Bertoni and A. T. Maiolo

    Article first published online : 24 APR 2009, DOI: 10.1111/j.1600-0609.1998.tb01039.x

  10. Characterization of the induction of persistence of major histocompatibility complex class II by hybrids of macrophages from Bacillus Calmette Guerin-resistant mice

    European Journal of Immunology

    Volume 21, Issue 4, April 1991, Pages: 1047–1052, Mary Faris and Bruce S. Zwilling

    Article first published online : 22 NOV 2005, DOI: 10.1002/eji.1830210428

  11. Interferon-α prevents endotoxin-induced mortality in mice

    European Journal of Immunology

    Volume 22, Issue 12, December 1992, Pages: 3097–3101, Shie-Pon Tzung, Thomas C. Mahl, Peter Lance, Valerie Andersen and Stefan A. Cohen

    Article first published online : 23 NOV 2005, DOI: 10.1002/eji.1830221211

  12. You have full text access to this OnlineOpen article
    Recombinant interferon-γ lacks activity against metastatic colorectal cancer but increases serum levels of ca 19-9

    Cancer

    Volume 63, Issue 10, 15 May 1989, Pages: 1998–2004, Michael J. O'Connell, Roy A. Ritts JR, Charles G. Moertel, Allan J. Schutt and Stephen A. Sherwin

    Article first published online : 29 JUN 2006, DOI: 10.1002/1097-0142(19890515)63:10<1998::AID-CNCR2820631022>3.0.CO;2-L

  13. Growth-inhibitory activity of interferon-beta against human colorectal carcinoma cell lines

    International Journal of Cancer

    Volume 43, Issue 3, 15 March 1989, Pages: 526–530, Vicky L. Y. Wong, Dave J. Rieman, Lori Aronson, Barbara J. Dalton, Russell Greig and Mario A. Anzano

    Article first published online : 17 JUL 2006, DOI: 10.1002/ijc.2910430331

  14. You have full text access to this OnlineOpen article
    Long term treatment of myeloproliferative disease with interferon-α-2b

    Cancer

    Volume 83, Issue 6, 15 September 1998, Pages: 1205–1213, Harriet S. Gilbert

    Article first published online : 9 NOV 2000, DOI: 10.1002/(SICI)1097-0142(19980915)83:6<1205::AID-CNCR21>3.0.CO;2-8

  15. You have full text access to this OnlineOpen article
    Nitric oxide is an effector molecule in inhibition of tumor cell growth by rIFN-γ-activated rat neutrophils

    International Journal of Cancer

    Volume 71, Issue 2, 10 April 1997, Pages: 223–230, Takao Yamashita, Tetsuro Uchida, Akemi Araki and Fujiro Sendo

    Article first published online : 6 DEC 1998, DOI: 10.1002/(SICI)1097-0215(19970410)71:2<223::AID-IJC17>3.0.CO;2-I

  16. Recombinant interferon-γ inhibits the mitogenic effect of platelet-derived growth factor at a level distal to the growth factor receptor

    Journal of Cellular Physiology

    Volume 134, Issue 3, March 1988, Pages: 396–404, M. Hosang

    Article first published online : 4 FEB 2005, DOI: 10.1002/jcp.1041340310

  17. Interferon-γ and tumor necrosis factor induce the L-arginine-dependent cytotoxic effector mechanism in murine macrophages*

    European Journal of Immunology

    Volume 18, Issue 10, October 1988, Pages: 1587–1592, Jean-Claude Drapier, Juana Wietzerbin and John B. Hibbs Jr

    Article first published online : 22 NOV 2005, DOI: 10.1002/eji.1830181018

  18. You have full text access to this OnlineOpen article
    IL-4 and IL-13 regulate the induction of indoleamine 2,3-dioxygenase activity and the control of Toxoplasma gondii replication in human fibroblasts activated with IFN-γ

    European Journal of Immunology

    Volume 31, Issue 2, February 2001, Pages: 333–344, Andréa C. L. Chaves, Isabela P. Cerávolo, Juliana A. S. Gomes, Carlos L. Zani, Alvaro J. Romanha and Ricardo T. Gazzinelli

    Article first published online : 22 JAN 2001, DOI: 10.1002/1521-4141(200102)31:2<333::AID-IMMU333>3.0.CO;2-X

  19. Characterization of the human type I interferon receptor by ligand blotting

    European Journal of Immunology

    Volume 18, Issue 12, December 1988, Pages: 2009–2014, Michael Schwabe, Gerald L. Princler and Connie R. Faltynek

    Article first published online : 1 DEC 2005, DOI: 10.1002/eji.1830181221

  20. You have full text access to this OnlineOpen article
    Hepatitis C virus dynamics in vivo: Effect of ribavirin and interferon alfa on viral turnover

    Hepatology

    Volume 28, Issue 1, July 1998, Pages: 245–252, Prof. med. Stefan Zeuzem, Jürgen M. Schmidt, Jung-hun Lee, Michael von Wagner, Gerlinde Teuber and W. Kurt Roth

    Article first published online : 30 DEC 2003, DOI: 10.1002/hep.510280132